ABEVAmbev S.A.
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Price is +9% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
A token position, settled Sep 15, 2026, about a week of normal trading to cover. Up 7.0% since the previous count, unchanged over three months.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ABEV is trading
Ambev S.A. is +40% over the past year while the S&P 500 is +18%: 21 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +9.1%
vs 200-day average · close to trend
- RSI (14)
- 64
RSI (14) · neutral
- Below its 52-week high
- 6.4%
Below its 52-week high
Details›
- Last close2026-10-09
- $3.20
- 1 monthS&P 500 +2.7%
- +5.1%
- 1 yearS&P 500 +18%
- +40%
- 5 yearsS&P 500 +88%
- +31%
- vs 50-day average$2.97
- +7.8%
- 52-week high
- $3.42
- 52-week low
- $2.10
- Annualised volatility
- 31%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$2.1M
| Year | Return |
|---|---|
| 2026 (year to date) | +30% |
| 2025 | +37% |
| 2024 | −30% |
| 2023 | +8.4% |
| 2022 | +2.4% |
| 2021 | −4.4% |
| 2020 | −33% |
| 2019 | +22% |
| 2018 | −37% |
| 2017 | +35% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +2.5% |
| Feb | 10 | 4 of 10 | −1.3% |
| Mar | 10 | 6 of 10 | +0.94% |
| Apr | 10 | 3 of 10 | −1.3% |
| May | 10 | 4 of 10 | +1.0% |
| Jun | 10 | 3 of 10 | −0.80% |
| Jul | 11 | 6 of 11 | +2.5% |
| Aug | 11 | 6 of 11 | −3.1% |
| Sep | 11 | 6 of 11 | −0.64% |
| Oct | 11 | 4 of 11 | −0.83% |
| Nov | 10 | 4 of 10 | +1.5% |
| Dec | 10 | 5 of 10 | +2.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.